Khattar Jack A. Insider Trading Activity (CGTX)

Profile

Jack A. Khattar is the President and CEO of Supernus Pharmaceuticals, Inc., a company focused on developing treatments for central nervous system diseases. He has held various leadership roles within the pharmaceutical industry, contributing to the growth and commercialization of specialty drugs.

Role	Director
Notability	50/100

Board memberships

Supernus Pharmaceuticals, Inc.
scPharmaceuticals Inc.

Awards & honors

Leadership in developing CNS treatments
CEO of Supernus Pharmaceuticals
Director at scPharmaceuticals Inc.

Recent Transactions

Date	Ticker	Company	Code	Shares	Price	Value
2026-06-22	CGTX	COGNITION THERAPEUTICS INC	A — Grant or award	25.0K	$0.00
2026-03-16	SUPN	SUPERNUS PHARMACEUTICALS, INC.	S — Open-market sale [10b5-1]	120	$51.75	$6K
2026-03-16	SUPN	SUPERNUS PHARMACEUTICALS, INC.	S — Open-market sale [10b5-1]	10.7K	$51.00	$548K
2026-03-16	SUPN	SUPERNUS PHARMACEUTICALS, INC.	S — Open-market sale [10b5-1]	24.1K	$50.09	$1.21M
2026-03-16	SUPN	SUPERNUS PHARMACEUTICALS, INC.	J — Other acquisition / disposition [10b5-1]	12.5K	—
2026-03-16	SUPN	SUPERNUS PHARMACEUTICALS, INC.	J — Other acquisition / disposition [10b5-1]	12.5K	—
2026-03-10	SUPN	SUPERNUS PHARMACEUTICALS, INC.	F — Tax withholding / forfeiture	16.6K	$54.73	$907K
2026-03-10	SUPN	SUPERNUS PHARMACEUTICALS, INC.	M — Option exercise	38.6K	$0.00
2025-10-09	SUPN	SUPERNUS PHARMACEUTICALS, INC.	S — Open-market sale	1.5K	$51.46	$79K
2025-10-09	SUPN	SUPERNUS PHARMACEUTICALS, INC.	S — Open-market sale	58.4K	$50.55	$2.95M
2025-10-09	SUPN	SUPERNUS PHARMACEUTICALS, INC.	M — Option exercise	81.2K	$25.30	$2.06M
2025-10-07	SCPH	scPharmaceuticals Inc.	J — Other acquisition / disposition	5.0K	—
2025-10-02	SUPN	SUPERNUS PHARMACEUTICALS, INC.	S — Open-market sale	1.9K	$48.06	$92K
2025-10-02	SUPN	SUPERNUS PHARMACEUTICALS, INC.	M — Option exercise	2.3K	$25.30	$57K
2025-10-01	SUPN	SUPERNUS PHARMACEUTICALS, INC.	S — Open-market sale	40.2K	$48.07	$1.93M
2025-10-01	SUPN	SUPERNUS PHARMACEUTICALS, INC.	M — Option exercise	53.8K	$25.30	$1.36M
2025-09-30	SUPN	SUPERNUS PHARMACEUTICALS, INC.	S — Open-market sale	8.6K	$48.25	$414K
2025-09-30	SUPN	SUPERNUS PHARMACEUTICALS, INC.	M — Option exercise	11.5K	$25.30	$291K
2025-09-29	SUPN	SUPERNUS PHARMACEUTICALS, INC.	S — Open-market sale	10.2K	$48.02	$491K
2025-09-29	SUPN	SUPERNUS PHARMACEUTICALS, INC.	M — Option exercise	13.7K	$25.30	$346K

Frequently Asked Questions

Who is Khattar Jack A.?

How many SEC Form 4 filings has Khattar Jack A. submitted recently?

1 primary Form 4 filings in the last 90 days, covering 1 company.

Has Khattar Jack A. been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 22 open-market sales ($29.43M) across all tracked filings.

Where can I see all of Khattar Jack A.'s SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Khattar Jack A. — SEC Form 4 Insider Trading Activity

Summary